Package Leaflet: Information for the User
Lantus 100units/ml solution for injection in a cartridge
Insulin glargine
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.The instructions for using the insulin pen are provided with your insulin pen. Read them before using your medicine.
Contents of the pack
Lantus contains insulin glargine. This is a modified insulin, very similar to human insulin.
Lantus is used to treat diabetes mellitus in adult, adolescent, and child patients from 2 years of age. Diabetes mellitus is a disease in which your body does not produce enough insulin to control your blood sugar levels. Insulin glargine has a long-acting, constant effect on reducing blood sugar levels.
Do not use Lantus
If you are allergic to insulin glargine or any of the other ingredients of this medicine (listed in section 6).
Warnings and precautions
Consult your doctor, pharmacist, or nurse before using Lantus.
Strictly follow the instructions regarding dosage, control (blood and urine tests), diet, and physical activity (work and exercise) that you have established with your doctor.
If your blood sugar level is too low (hypoglycemia), follow the guidelines for hypoglycemia (see the box at the end of this leaflet).
Travel
Before traveling, consult your doctor. You may need to discuss:
Illnesses and injuries
The management of your diabetes may require special care in the following situations (e.g., adjusting your insulin dose, blood and urine tests):
In most cases, you will need to see a doctor. Make sure to consult a doctor immediately.
If you have type 1 diabetes (insulin-dependent diabetes mellitus), do not stop taking your insulin and continue to take enough carbohydrates. Always inform the people responsible for your care or treatment that you need insulin.
Treatment with insulin can cause your body to produce antibodies to insulin (substances that act against insulin). However, only in very rare cases will you need to change your insulin dose.
Some patients with long-standing type 2 diabetes mellitus and previous heart disease or stroke who were treated with pioglitazone (an oral antidiabetic medication used to treat type 2 diabetes mellitus) and insulin developed heart failure. Inform your doctor as soon as possible if you experience signs of heart failure such as unusual shortness of breath or rapid weight gain or localized swelling (edema).
Children
There is no experience with the use of Lantus in children under 2 years of age.
Using Lantus with other medicines
Some medicines can change your blood sugar levels (increase, decrease, or both, depending on the situation). In each case, it may be necessary to adjust your insulin dose to avoid too low or too high blood sugar levels. Be careful when starting to take another medicine and also when stopping it.
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines. Ask your doctor before taking a medicine if it can affect your blood sugar level and what measures you should take in your case.
Among the medicines that can cause a decrease in your blood sugar level (hypoglycemia) are:
Among the medicines that can cause an increase in your blood sugar level (hyperglycemia) are:
Your blood sugar level may rise or fall if you take:
Pentamidine (used to treat some parasitic infections) can cause hypoglycemia, which may sometimes be followed by hyperglycemia.
Beta-blockers, like other sympatholytic medications (such as clonidine, guanethidine, and reserpine), can mask or completely suppress the early warning symptoms that could help you recognize hypoglycemia.
If you are not sure if you are taking any of these medicines, ask your doctor or pharmacist.
Using Lantus with alcohol
Your blood sugar levels may rise or fall if you drink alcohol.
Pregnancy and breastfeeding
Consult your doctor or pharmacist before using any medicine.
Tell your doctor if you are planning to become pregnant or if you are already pregnant. Your insulin dose may need to be changed during pregnancy and after delivery. Very careful control of your diabetes and prevention of hypoglycemia are important for your baby's health.
If you are breastfeeding, consult your doctor, as you may need to adjust your insulin dose and diet.
Driving and using machines
Your ability to concentrate or react may be reduced if:
Be aware of this possible problem, considering all situations that may pose a risk to you or others (such as driving a vehicle or using machines). You should ask your doctor for advice about your ability to drive if:
Important information about some of the ingredients of Lantus
This medicine contains less than 1 mmol (23 mg) of sodium per dose, i.e., it is essentially "sodium-free".
Follow exactly the instructions for administering this medicine as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
Although Lantus contains the same active substance as Toujeo (insulin glargine 300 units/ml), these medicines are not interchangeable. Switching from one insulin treatment to another requires a doctor's prescription, medical supervision, and blood glucose monitoring. For more information, consult your doctor.
Dose
Based on your lifestyle and the results of your blood sugar (glucose) tests and your previous insulin treatment, your doctor:
Lantus is a long-acting insulin. Your doctor may indicate that you use it in combination with a short-acting insulin or with tablets to treat high blood sugar levels.
Many factors can influence your blood sugar level. You should be aware of these factors so that you can react correctly to changes in your blood sugar level and avoid it becoming too high or too low. For more information, see the box at the end of the leaflet.
Use in children and adolescents
Lantus can be used in adolescents and children from 2 years of age. Use this medicine as your doctor has told you.
Frequency of administration
You need to inject Lantus once a day, always at the same time.
Method of administration
Lantus is injected under the skin. DO NOT inject Lantus into a vein, as this will change its action and may cause hypoglycemia.
Your doctor will show you which area of the skin to inject Lantus into. With each injection, you should change the injection site within the specific area of skin you are using.
How to handle the cartridges
To ensure you get the exact dose, Lantus cartridges should only be used with the following pens:
In your country, only some of these pens may be available.
The pen should be used as recommended in the information provided by the device manufacturer.
The manufacturer's instructions for using the pen should be carefully followed when loading the cartridge, inserting the needle, and administering the insulin injection.
Keep the cartridge at room temperature for 1 to 2 hours before inserting it into the pen.
Inspect the cartridge before using it. It should only be used if the solution is clear, colorless, and aqueous, and does not contain visible particles. Do not shake or mix before use.
Always use a new cartridge if you notice that your blood sugar control is worsening unexpectedly. This is because the insulin may have lost some of its effectiveness. If you think you may have a problem with Lantus, have it checked by your doctor or pharmacist.
Special precautions before injection
Before injection, any air bubbles that form must be eliminated (see the pen's instructions for use).
Make sure the insulin is not contaminated with alcohol or other disinfectants, or with other substances. Do not refill or reuse empty cartridges. Do not add any other insulin to the cartridge. Do not mix Lantus with any other insulin or medicine. Do not dilute it. Mixing or diluting may change the action of Lantus.
Problems with the insulin pen?
Consult the manufacturer's instructions for the pen.
If your insulin pen is damaged or does not work properly (due to mechanical problems), it must be discarded and a new insulin pen used.
If the insulin pen does not work properly, the insulin can be withdrawn from the cartridge and injected with a syringe. Therefore, you should also carry syringes and needles for injection. However, only syringes designed for an insulin concentration of 100 units per milliliter should be used.
Insulin confusion
Always check the insulin label before each injection to avoid confusion between Lantus and other insulins.
If you use more Lantus than you should
Check your blood sugar level frequently. In general, to prevent hypoglycemia, you should eat more and monitor your blood sugar level. For more information on treating hypoglycemia, see the box at the end of the leaflet.
If you forget to use Lantus
For more information on treating hyperglycemia, see the box at the end of the leaflet.
If you stop using Lantus
This could lead to severe hyperglycemia (very high blood sugar levels) and ketoacidosis (increased acid in the blood because the body breaks down fat instead of sugar). Do not stop using Lantus without consulting your doctor; they will tell you what to do.
If you have any other questions about using this medicine, ask your doctor, pharmacist, or nurse.
Like all medicines, Lantus can cause adverse effects, although not all people suffer from them.
If you notice signs that your blood sugar level is too low (hypoglycemia),act immediately to raise your blood sugar level (see the box at the end of this prospectus). Hypoglycemia (low blood sugar) can be very serious and is very common during insulin treatment (it can affect more than 1 in 10 people). Low blood sugar means that there is not enough sugar in the blood. If your blood sugar level drops too low, you may faint (lose consciousness). Severe hypoglycemia can cause brain damage and can be potentially fatal. For more information, see the box at the end of this prospectus.
Severe allergic reactions(rare, may affect up to 1 in 1,000 people) – the signs may include large-scale skin reactions (skin rash and itching all over the body), severe swelling of the skin or mucous membranes (angioedema), difficulty breathing, low blood pressure with rapid heartbeat and sweating. Severe allergic reactions to insulin can be potentially fatal. Inform your doctor immediately if you notice signs of severe allergic reactions.
Common adverse effects(may affect up to 1 in 10 people)
If insulin is injected too frequently at the same point on the skin, the fatty tissue under this point may shrink (lipoatrophy, may affect up to 1 in 100 people) or thicken (lipohipertrophy). The insulin may not work very well. Change the injection site with each injection to help prevent these skin changes.
The signs may include redness, intense pain when injecting, itching, hives, swelling, or inflammation. These reactions may spread around the injection site. Most mild reactions to insulin usually disappear within a few days or weeks.
Rare adverse effects(may affect up to 1 in 1,000 people)
A significant change (improvement or worsening) in blood sugar control may temporarily alter your vision. If you have proliferative retinopathy (a vision disease related to diabetes), severe hypoglycemic attacks may cause temporary vision loss.
In rare cases, insulin treatment may also cause temporary water retention in the body, with swelling of the calves and ankles.
Very rare adverse effects(may affect up to 1 in 10,000 people)
In very rare cases, disgeusia (taste disorders) and myalgia (muscle pain) may occur.
Use in children and adolescents
In general, adverse effects in children and adolescents 18 years or younger are similar to those in adults.
Claims about reactions at the injection site (injection site pain, injection site reaction) and skin reactions (rash, hives) have been reported more frequently in children and adolescents 18 years or younger than in adults.
There is no experience in children under 2 years of age.
Reporting of adverse effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that is not listed in this prospectus. You can also report them directly through the national reporting system included in Appendix V. By reporting adverse effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiration date stated on the packaging and on the cartridge label after CAD/EXP. The expiration date is the last day of the month indicated.
Unopened cartridges
Store in a refrigerator (between 2°C and 8°C). Do not freeze or place near the freezer or a cold accumulator. Keep the cartridge in the outer packaging to protect it from light.
Cartridges in use
Cartridges in use (in the insulin pen) or to be carried as a reserve may be stored for a maximum of 4 weeks below 30°C and protected from direct heat or direct light. The cartridge in use in the insulin pen should not be stored in the refrigerator. Do not use after this period.
Do not use Lantus if you notice any particles inside. Lantus should only be used if the solution is clear, colorless, and aqueous.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of the packaging and medicines you no longer need. This will help protect the environment.
Composition of Lantus
Appearance of the Product and Package Contents
Lantus 100 units/ml injectable solution in a cartridge is a clear and colorless solution.
Lantus is presented in a special cartridge to be used only with the OptiPen, ClikSTAR, Tactipen, Autopen 24, AllStar, AllStar PRO, or JuniorSTAR pens. Each cartridge contains 3 ml of injectable solution (equivalent to 300 units).
Packaging of 1, 3, 4, 5, 6, 8, 9, and 10 cartridges. Only some packaging sizes may be marketed.
Marketing Authorization Holder and Manufacturer
Sanofi-Aventis Deutschland GmbH, D-65926 Frankfurt am Main, Germany.
You can request more information about this medicine by contacting the local representative of the marketing authorization holder.
België/Belgique/Belgien Sanofi Belgium Tel: +32 (0)2 710 54 00 | Lietuva UAB «SANOFI-AVENTIS LIETUVA» Tel: +370 5 2755224 |
???????? SANOFI BULGARIA EOOD Tel: +359 (0)2 970 53 00 | Luxembourg/Luxemburg Sanofi Belgium Tel: +32 (0)2 710 54 00 (Belgique/Belgien) |
Ceská republika sanofi-aventis, s.r.o. Tel: +420 233 086 111 | Magyarország sanofi-aventis zrt., Magyarország Tel: +36 1 505 0050 |
Danmark sanofi-aventis Denmark A/S Tlf: +45 45 16 70 00 | Malta Sanofi Malta Ltd Tel: +356 21493022 |
Deutschland Sanofi-Aventis Deutschland GmbH Tel: +49 (0)180 2 222010 | Nederland sanofi-aventis Netherlands B.V. Tel: +31 (0)182 557 755 |
Eesti sanofi-aventis Estonia OÜ Tel: +372 627 34 88 | Norge sanofi-aventis Norge AS Tlf: +47 67 10 71 00 |
Ελλ?δα sanofi-aventis AEBE Τηλ: +30 210 900 16 00 | Österreich sanofi-aventis GmbH Tel: +43 1 80 185 – 0 |
España sanofi-aventis, S.A. Tel: +34 93 485 94 00 | Polska sanofi-aventis Sp. z o.o. Tel: +48 22 280 00 00 |
France sanofi-aventis France Tél: 0 800 222 555 Appel depuis l’étranger : +33 1 57 63 23 23 | Portugal Sanofi - Produtos Farmacêuticos, Lda Tel: +351 21 35 89 400 |
Hrvatska sanofi-aventis Croatia d.o.o. Tel: +385 1 600 34 00 | România Sanofi Romania Tel: +40 (0) 21 317 31 36 |
Ireland sanofi-aventis Ireland Ltd. T/A SANOFI Tel: +353 (0) 1 403 56 00 | Slovenija sanofi-aventis d.o.o. Tel: +386 1 560 48 00 |
Ísland Vistor hf. Sími: +354 535 7000 | Slovenská republika sanofi-aventis Pharma Slovakia s.r.o. Tel: +421 2 33 100 100 |
Italia Sanofi Tel: 800 13 12 12 (technical questions) 800.536389 (other questions) | Suomi/Finland Sanofi Oy Puh/Tel: +358 (0) 201 200 300 |
Κ?προς sanofi-aventis Cyprus Ltd. Τηλ: +357 22 871600 | Sverige Sanofi AB Tel: +46 (0)8 634 50 00 |
Latvija sanofi-aventis Latvia SIA Tel: +371 67 33 24 51 | United Kingdom Sanofi Tel: +44 (0) 845 372 7101 |
Other Sources of Information
Detailed information about this medicine is available on the European Medicines Agency website: http://www.ema.europa.eu/
––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
HYPERGLYCEMIA AND HYPOGLYCEMIA
Always carry something sweet with you (at least 20 grams).
Always carry some information that indicates you are diabetic.
HYPERGLYCEMIA (high blood sugar levels)
If you have a very high blood sugar level (hyperglycemia), you may not have injected enough insulin.
Why do you get hyperglycemia?
Some examples are:
Warning signs of hyperglycemia
Thirst, increased need to urinate, fatigue, dry skin, redness of the face, loss of appetite, low blood pressure, rapid heartbeat, and the presence of glucose and ketone bodies in the urine. Stomach pain, deep and rapid breathing, drowsiness, or even loss of consciousness may be signs of a serious condition (ketoacidosis) due to lack of insulin.
What should you do if you suffer from hyperglycemia?
You should analyze your blood sugar level and your acetone level in the urine as soon as any of the above symptoms occur.Severe hyperglycemia or ketoacidosis should always be treated by a doctor, usually in a hospital.
HYPOGLYCEMIA (low blood sugar levels)
If your blood sugar level drops too low, you may lose consciousness. Severe hypoglycemia can cause a heart attack or brain damage and can be life-threatening. Normally, you should be able to recognize when your blood sugar level is dropping too low to take the necessary measures.
Why do you get hypoglycemia?
Some examples are:
It is also more likely that hypoglycemia will occur if:
Warning signs of hypoglycemia
Examples that indicate your blood sugar level is dropping too low or too quickly: sweating, sticky skin, anxiety, rapid heartbeat, high blood pressure, palpitations, and irregular heartbeat. These symptoms often occur before the symptoms of low blood sugar in the brain appear.
Examples that indicate there is a low blood sugar level in the brain: headaches, intense hunger, nausea, vomiting, fatigue, drowsiness, sleep disorders, restlessness, aggressive behavior, concentration problems, altered reactions, depression, confusion, speech disorders (sometimes, complete loss of speech), vision problems, tremors, paralysis, tingling sensations (paresthesias), numbness and tingling sensations in the mouth area, dizziness, loss of self-control, feeling of helplessness, seizures, loss of consciousness.
The first warning signs of hypoglycemia ("warning symptoms") may change, weaken, or be absent if
In this case, you may suffer from severe hypoglycemia (and even faint) before you realize the problem. Always be familiar with your warning symptoms. If necessary, more frequent blood sugar analysis can help identify mild hypoglycemic episodes that would otherwise go unnoticed. If you are not sure you can recognize your warning symptoms, avoid situations (such as driving a car) that could put you or others in danger due to hypoglycemia.
What should you do if you suffer from hypoglycemia?
Recovery from hypoglycemia may be delayed because Lantus has a prolonged action.
Tell your family, friends, and people close to you:
If you are unable to swallow or lose consciousness, you will need an injection of glucose or glucagon (a medication that increases blood sugar levels). These injections are justified even if you are not sure you have hypoglycemia.
It is recommended to analyze your blood sugar level immediately after ingesting glucose to confirm that you actually have hypoglycemia.